A prospective, randomized trial to assess a protease inhibitor-based regimen switch strategy to manage integrase inhibitor-related weight gain

被引:0
|
作者
Short, W. R. [1 ]
Ramgopal, M. [2 ]
Hagins, D. P. [3 ]
Lee, J. [4 ]
Simonson, R. B. [4 ]
Hsu, T. -H. [4 ]
Xu, P. [5 ]
Anderson, D. [4 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[2] Midway Immunol & Res Ctr, Ft Pierce, FL USA
[3] Chatham CARE Ctr, Savannah, GA USA
[4] Janssen Sci Affairs LLC, Titusville, FL USA
[5] Janssen Res & Dev LLC, Titusville, FL USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OALBB0502
引用
收藏
页数:1
相关论文
共 45 条
  • [1] DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain
    Anderson, David
    Ramgopal, Moti
    Hagins, Debbie P.
    Lee, Johnnie
    Simonson, Richard Bruce
    Hsu, Tien-Huei
    Xu, Ping
    Ahmad, Nina
    Short, William R.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [2] Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy
    Lake, Jordan E.
    Wu, Kunling
    Bares, Sara H.
    Debroy, Paula
    Godfrey, Catherine
    Koethe, John R.
    McComsey, Grace A.
    Palella, Frank J.
    Tassiopoulos, Katherine
    Erlandson, Kristine M.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : E471 - E477
  • [3] TRIAL WATCH HIV integrase inhibitor-based regimen beats market leader
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (09) : 664 - 664
  • [4] Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy
    Erlandson, Kristine M.
    Wu, Kunling
    Lake, Jordan E.
    Samuels, David C.
    Bares, Sara H.
    Tassiopoulos, Katherine
    Koethe, John R.
    Brown, Todd T.
    Leonard, Michael
    Benson, Constance A.
    Haas, David W.
    Hulgan, Todd
    AIDS, 2021, 35 (03) : 439 - 445
  • [5] The effect of a treatment switch to integrase Strand transfer inhibitor-based regimens on weight gain and other metabolic syndrome-related conditions
    Maman, Omer
    Abu Ahmad, Wiessam
    Perzon, Ofer
    Mahlab-Guri, Keren
    Elbirt, Daniel
    Elinav, Hila
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [6] Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
    Goldberg, Rachel N.
    Kania, Alexandra T.
    Michienzi, Sarah M.
    Patel, Mahesh
    Badowski, Melissa E.
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2021, 20
  • [7] Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens
    Norwood, Jamison
    Turner, Megan
    Bofill, Carmen
    Rebeiro, Peter
    Shepherd, Bryan
    Bebawy, Sally
    Hulgan, Todd
    Raffanti, Stephen
    Haas, David W.
    Sterling, Timothy R.
    Koethe, John R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 76 (05) : 527 - 531
  • [8] Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain
    Calza, Leonardo
    Giglia, Maddalena
    Colangeli, Vincenzo
    Bon, Isabella
    Vitale, Salvatore
    Viale, Pierluigi
    HIV MEDICINE, 2024, 25 (08) : 919 - 926
  • [9] Weight gain after switching to integrase inhibitor-based ART is not associated with hepatic steatosis in HIV-infected patients
    Gonzalez-Serna, A.
    Macias, J.
    Rincon, P.
    Arriaza, M. J.
    Corma-Gomez, A.
    Santos, M.
    Fernandez-Fuertes, M.
    Real, L. M.
    Pineda, J. A.
    HIV MEDICINE, 2021, 22 : 88 - 89
  • [10] Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain
    Gonzalez-Serna, Alejandro
    Macias, Juan
    Rincon, Pilar
    Arriaza, Maria Jose
    Corma-Gomez, Anais
    Santos, Marta
    Fernandez-Fuertes, Marta
    Pineda, Juan Antonio
    Real, Luis Miguel
    AIDS, 2023, 37 (14) : 2259 - 2262